Home Mobile games Living community 5G technology Commercial street Fashion icon More

Entertainment games

GIGABYTE Unveils a Series of Groundbreaking AI Innovations for All at CES 2025

01-08

TAIPEI,Jan. 7,2025-- GIGABYTE,the world\'s leading computer brand,unveils groundbreaking AI innovations at CES 2025 with new AI-powered products,AI PCs,NVIDIA® GeForce RTX™ 50 Series graphics car

UGREEN to Showcase Pioneering NASync AI NAS Lineup and More at CES 2025

01-08

LAS VEGAS,Jan. 8,2025-- UGREEN,a leading innovator in consumer electronics,is due to showcase its latest innovations at CES 2025 under the theme of "Activate the Possibility of AI." The high

Lynk & Co Honors Exceptional Global Achievements in 2024

01-06

HANGZHOU,China,Jan. 3,2025--On January 1st,Lynk & Co announced its annual sales achievement. With 285,441 units sold worldwide,the brand has achieved a year-on-year growth of approximately 30%. In

Interest-Driven Consumption Sparks ¥ 500B ACG Goods Market, MINISO Rides the Wave

01-06

GUANGZHOU,China,Jan. 3,2025-- MINISO,a global lifestyle brand,recently announced its partnership with "Black Myth: Wukong",winner of the "Best Action Game" and "Players\' Voic

PacificLight Power Awarded Right to Build New Hydrogen-Ready Combined Cycle Gas Turbine Plant

01-06

SINGAPORE,Jan. 3,2025-- PacificLight Power Pte Ltd (PLP) is delighted to announce that it has been awarded the right to build,own,and operate a hydrogen-ready Combined Cycle Gas Turbine (CCGT) facilit

GRIT Bio Appoints Jie Jia, Ph.D., as Chief Operating Officer

01-06

SHENZHEN,China,Jan. 3,2025--Shenzhen GRIT Biotechnology Co.,Ltd.,a leading company in cell therapy globally,today announced the appointment of Jie Jia,Ph.D.,as Chief Operating Officer (COO),effective

Nona Biosciences Announces Update on Its Collaborator DualityBio's Antibody-Drug Conjugate (ADC) Collaboration with BeiGene

01-06

CAMBRIDGE,Mass.,Jan. 3,2025-- Nona Biosciences,a global biotechnology company providing a total solution from "Idea to IND" (I to ITM),today announcedthat BeiGene. Ltd. has exercised its ex

Innovent Announces Second New Drug Application of DOVBLERON ® (Taletrectinib Adipate Capsule, ROS1 Inhibitor) was Approved by China's National Medical Products Administration

01-06

SAN FRANCISCO and SUZHOU,China,Jan. 3,2025-- Innovent Biologics,Inc. ("Innovent") (HKEX: 01801),a world-class biopharmaceutical company that develops,manufactures and commercializes high qua

Global Times: China’s role as a stabilizing force crucial for 2025 and beyond

01-06

The year 2024 witnessed regional turmoil and profound landscape changes. From the Russia-Ukraine conflict to the chaos in the Middle East and the interference of external forces stirring tensions in the South China Sea, China demonstrated composure and confidence amid a turbulent landscape, creating a favorable external environment for its high-quality development and injecting valuable stability into a restless world. As a member of the Global South, China is playing an increasingly important role in promoting world development and peace, as well as advancing the rise of the Global South. As

Ractigen Therapeutics Announces First Patient Dosed in Phase I Clinical Trial for RAG-17 in SOD1-ALS

01-03

NANTONG and SUZHOU,China,Dec. 24,2024-- Ractigen Therapeutics,a clinical-stage pharmaceutical company dedicated to developing RNA-based innovative therapies,today announced the successful dosing of th

Home Previous 32 33 34 35 36 37 38 Next Tail

10 Items Per Page (Page 35 / 74) Total 733 Items

Disclaimer: This article is reproduced from other media. The purpose of reprinting is to convey more information. It does not mean that this website agrees with its views and is responsible for its authenticity, and does not bear any legal responsibility. All resources on this site are collected on the Internet. The purpose of sharing is for everyone's learning and reference only. If there is copyright or intellectual property infringement, please leave us a message.

Newest

Jewellery & Gem ASEAN Bangkok (JGAB) 2025: Connecting ASEAN's Gem and Jewellery Business to the Global Market

BioCity Biopharmaceutics Co., Ltd. Announces Clinical Collaboration to Evaluate BC3195 in Combination with KEYTRUDA® (pembrolizumab) in Patients with Locally Advanced or Metastatic Solid Tumors

Acer Reports FY2024 Net Income of NT$5.54 Billion and NT$1.7 Cash Dividend Per Share

Ping An #1 in Brand Finance's Global Insurance Brand Value for 9th Year, Brand Value Reaches $33.6 Billion

LITEON Showcase Groundbreaking Energy Savings in Private 5G Network with NTT EAST at MWC 2025

©Copyright 2009-2020 Startup Weekly    Contact Us  SiteMap